Twist Bioscience Balance Sheet Health
Financial Health criteria checks 5/6
Twist Bioscience has a total shareholder equity of $472.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $614.3M and $141.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$276.40m |
| Equity | US$472.69m |
| Total liabilities | US$141.63m |
| Total assets | US$614.32m |
Recent financial health updates
Twist Bioscience (NASDAQ:TWST) Is In A Strong Position To Grow Its Business
Sep 25
We Think Twist Bioscience (NASDAQ:TWST) Can Easily Afford To Drive Business Growth
Jun 10We're Not Very Worried About Twist Bioscience's (NASDAQ:TWST) Cash Burn Rate
Jan 22Twist Bioscience (NASDAQ:TWST) Is In A Good Position To Deliver On Growth Plans
Oct 05We Think Twist Bioscience (NASDAQ:TWST) Can Afford To Drive Business Growth
Jul 07Recent updates
Twist Bioscience: A Post-Earnings Assessment
Nov 18Twist Bioscience's Earnings Preview: Partnerships And Valuation Make It A 'Buy'
Nov 08Twist Bioscience (NASDAQ:TWST) Is In A Strong Position To Grow Its Business
Sep 25Investors Aren't Buying Twist Bioscience Corporation's (NASDAQ:TWST) Revenues
Aug 20Twist Bioscience: Lowered Biopharma Expectations Amid Financial Strain (Rating Downgrade)
Aug 04Twist Bioscience: Growing Customer Base And Technology Platform Make Me Like This Stock
Jul 26We Think Twist Bioscience (NASDAQ:TWST) Can Easily Afford To Drive Business Growth
Jun 10Twist Bioscience Corporation (NASDAQ:TWST) Shares Fly 29% But Investors Aren't Buying For Growth
May 04Twist Bioscience: NGS Is Taking Off
May 03Twist Bioscience Corporation (NASDAQ:TWST) Surges 26% Yet Its Low P/S Is No Reason For Excitement
Feb 27Twist Bioscience: Strong Performance In A Soft Market
Feb 07Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet
Jan 31We're Not Very Worried About Twist Bioscience's (NASDAQ:TWST) Cash Burn Rate
Jan 22Twist Bioscience Corporation's (NASDAQ:TWST) Price Is Right But Growth Is Lacking After Shares Rocket 44%
Dec 18Twist Bioscience (NASDAQ:TWST) Is In A Good Position To Deliver On Growth Plans
Oct 05We Think Twist Bioscience (NASDAQ:TWST) Can Afford To Drive Business Growth
Jul 07Financial Position Analysis
Short Term Liabilities: TWST's short term assets ($346.8M) exceed its short term liabilities ($71.0M).
Long Term Liabilities: TWST's short term assets ($346.8M) exceed its long term liabilities ($70.6M).
Debt to Equity History and Analysis
Debt Level: TWST is debt free.
Reducing Debt: TWST has no debt compared to 5 years ago when its debt to equity ratio was 5.1%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TWST has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if TWST has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.